Search for: "NOVARTIS AG"
Results 41 - 60
of 440
Sort by Relevance
|
Sort by Date
20 Aug 2021, 12:15 pm
Consolidation of Tasigna Drug Injury Cases Involving Atherosclerosis-related Diseases and Medical Conditions (Posted by Tom Lamb at Drug Injury Watch) On August 12, 2021, the United States Judicial Panel on Multidistrict Litigation (JPML) created a new federal court multi-district litigation (MDL) matter for Novartis AG's cancer drug Tasigna. [read post]
11 Aug 2021, 12:57 pm
Sarepta Technologies SANGENTRI 90382648 Novartis AG UAMG Content, LLC BILLIONAIRE U. 90394028 Majestas Sarl Spectrum Brands, Inc. [read post]
Beovu Vision Loss Side Effects Continue to Plague Novartis, Ending 3 Key Clinical Trials in May 2021
1 Jun 2021, 2:55 pm
Novartis launched the Merlin trial to see if the more frequent dosing could help age-related macular degeneration patients who still have unresolved retinal fluid despite anti-VEGF therapy. [read post]
24 May 2021, 7:34 am
The plaintiffs have accused Ranbaxy of delaying the launch of generic versions of Novartis AG’s high blood pressure drug Diovan, Pfizer Inc’s acid reflux drug Nexium and Genentech Inc’s antiviral drug Valcyte. [read post]
26 Apr 2021, 7:42 am
Novartis AG is working with Pfizer Inc. to fill vials quicker and to develop the mRNA needed for a new vaccine candidate produced by CureVA NV. [read post]
10 Mar 2021, 12:13 pm
The basic liability allegations in those Beovu lawsuits, as well as other Beovu cases concerning Beovu eye problems, are: Novartis misrepresented that Beovu was a safe treatment for age-related macular degeneration; and, Novartis failed to warn about Beovu eye injection reactions causing vision loss and blindness. [read post]
1 Feb 2021, 11:27 am
Singh considers two cases, Bayer v Natco and Novartis AG v Union of India, to see how compulsory licensing of pharmaceuticals and evergreening of patents are dealt with by the Indian judiciary.Part VII “Lores of IP during wartime”Arpan Banerjee and Dana Beldiman, in Chapter 14, “International Trade Mark Enforcement Under the Versailles Treaty: A Case Study of Sanatogen”, discuss how the Bombay High Court applied IP-related provisions of the Versailles Treaty… [read post]
29 Jan 2021, 2:00 pm
In turn, during 2020 these Beovu side effects caused some eye doctors to avoid using Beovu injections for treatment of neovascular (wet) age-related macular degeneration (AMD). [read post]
27 Jan 2021, 11:07 am
Badboy pharmaceutical giant Novartis AG and two of its subsidiaries paid the DOJ and SEC $346.7 million. [read post]
8 Jan 2021, 3:49 am
.'" Novartis AG v. [read post]
7 Jan 2021, 1:32 pm
To start, Beovu was approved by the FDA on October 7, 2019, to treat wet age-related macular degeneration. [read post]
31 Dec 2020, 7:03 am
Department of Justice announced Novartis AG, a global pharmaceutical and healthcare company based in Switzerland, agreed to pay over $300 million in sanctions to resolve FCPA charges for bribery in Greece. [read post]
28 Nov 2020, 8:06 am
Beovu was supposed to be the big new revenue-making drug for pharmaceutical giant Novartis last year. [read post]
20 Nov 2020, 12:13 pm
Beovu is manufactured by the Swiss pharmaceutical giant Novartis. [read post]
17 Nov 2020, 12:30 pm
The American Society of Retina Specialists Research and Safety in Therapeutics (ReST) committee began to receive reports of intraocular inflammation alone and retinal vasculitis in patients who underwent injections of Beovu (brolucizumab, Novartis) following its FDA approval for neovascular age-related macular degeneration in October 2019. [read post]
15 Nov 2020, 6:48 am
Hague District Court grants cross-border preliminary injunction against Mylan in Novartis SPC battle | Invalidating a patent after expiry of the patent term? [read post]
10 Nov 2020, 1:06 pm
Novartis AG, California Superior Court, Los Angeles Cty., Transcript of Oral Argument on Post-Trial Motions, at 46 -47 (March 18, 2004) (Hon. [read post]
10 Nov 2020, 5:06 am
Novartis AG, California Superior Court, Los Angeles Cty., Transcript of Oral Argument on Post-Trial Motions, at 46 -47 (March 18, 2004) (Hon. [read post]
30 Oct 2020, 1:30 pm
Beovu Legal Cases Involve Retinal Artery Occlusion, Retinal Vasculitis, Intraocular Inflammation, Other Eye Problems (Posted by Tom Lamb at DrugInjuryWatch.com) Beovu (brolucizumab) is prescribed for the treatment of neovascular (wet) age-related macular degeneration (AMD). [read post]
29 Sep 2020, 3:40 pm
[Beovu (brolucizumab)] is not the only drug that can be used for the treatment of [exudative age-related macular degeneration (eAMD)]. [read post]
